Healthcare >> CEO Interviews >> June 18, 2001
DAVID CHAZANOVITZ joined Cambridge Heart in October 2000 with 28 years
experience in sales, marketing and general management of medical
products businesses, ranging from early stage device companies to
larger, more established businesses. He has been active in developing
products, marketing and selling to many different medical specialties
including electrophysiology, interventional cardiology and radiology,
pediatric cardiology, gastroenterology, and general surgery. For the
past five years Mr. Chazanovitz has worked as a Divisional President for
NMT Medical, initially with total responsibility for establishing a
startup effort to develop a new cardiac technology and more recently as
President of their Neurosciences Division. Mr. Chazanovitz has also held
the position of President for several divisions of C.R. Bard, Inc.,
including Bard Ventures, Bard Electrophysiology Division and USCI
Angiography Division. Mr. Chazanovitz earned a Bachelor of Science
degree in Biology from City College of New York and an MBA in Marketing
from Long Island University. Profile
and then a profile of things as they are now?
Mr. Chazanovitz: The company was founded back in 1990 out of a
technology
